History of myeloid-derived suppressor cells
JE Talmadge, DI Gabrilovich - Nature Reviews Cancer, 2013 - nature.com
Tumour-induced granulocytic hyperplasia is associated with tumour vasculogenesis and
escape from immunity via T cell suppression. Initially, these myeloid cells were identified as …
escape from immunity via T cell suppression. Initially, these myeloid cells were identified as …
[HTML][HTML] Challenges and strategies for in situ endothelialization and long-term lumen patency of vascular grafts
Y Zhuang, C Zhang, M Cheng, J Huang, Q Liu… - Bioactive Materials, 2021 - Elsevier
Vascular diseases are the most prevalent cause of ischemic necrosis of tissue and organ,
which even result in dysfunction and death. Vascular regeneration or artificial vascular graft …
which even result in dysfunction and death. Vascular regeneration or artificial vascular graft …
Integrins in angiogenesis and lymphangiogenesis
CJ Avraamides, B Garmy-Susini, JA Varner - Nature Reviews Cancer, 2008 - nature.com
Blood vessels promote tumour growth, and both blood and lymphatic vessels facilitate
tumour metastasis by serving as conduits for the transport of tumour cells to new sites …
tumour metastasis by serving as conduits for the transport of tumour cells to new sites …
Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling
S Rey, GL Semenza - Cardiovascular research, 2010 - academic.oup.com
The vascular system delivers oxygen and nutrients to every cell in the vertebrate organism.
Hypoxia-inducible factor 1 (HIF-1) is a master regulator of hypoxic/ischaemic vascular …
Hypoxia-inducible factor 1 (HIF-1) is a master regulator of hypoxic/ischaemic vascular …
The SDF-1–CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis
I Petit, D Jin, S Rafii - Trends in immunology, 2007 - cell.com
Pro-angiogenic bone marrow (BM) cells include subsets of hematopoietic cells that provide
vascular support and endothelial progenitor cells (EPCs), which under certain permissive …
vascular support and endothelial progenitor cells (EPCs), which under certain permissive …
Vascular repair by endothelial progenitor cells
A Zampetaki, JP Kirton, Q Xu - Cardiovascular research, 2008 - academic.oup.com
Accumulating evidence indicates the impact of endothelial progenitor cells (EPCs) in
vascular repair. In patients, the number of EPCs is negatively correlated with the severity of …
vascular repair. In patients, the number of EPCs is negatively correlated with the severity of …
Postischemic revascularization: from cellular and molecular mechanisms to clinical applications
JS Silvestre, DM Smadja, BI Levy - Physiological reviews, 2013 - journals.physiology.org
After the onset of ischemia, cardiac or skeletal muscle undergoes a continuum of molecular,
cellular, and extracellular responses that determine the function and the remodeling of the …
cellular, and extracellular responses that determine the function and the remodeling of the …
Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression
Myocardial infarction rapidly depletes the endogenous cardiac progenitor cell pool, and the
inefficient recruitment of exogenously administered progenitor cells limits the effectiveness …
inefficient recruitment of exogenously administered progenitor cells limits the effectiveness …
Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy
GP Fadini, S Sartore, M Albiero, I Baesso… - … , and vascular biology, 2006 - Am Heart Assoc
Objective—Peripheral arterial disease (PAD) is a threatening complication of diabetes. As
endothelial progenitor cells (EPCs) are involved in neovasculogenesis and maintenance of …
endothelial progenitor cells (EPCs) are involved in neovasculogenesis and maintenance of …
Unchain my heart: the scientific foundations of cardiac repair
S Dimmeler, AM Zeiher… - The Journal of clinical …, 2005 - Am Soc Clin Investig
In humans, the biological limitations to cardiac regenerative growth create both a clinical
imperative—to offset cell death in acute ischemic injury and chronic heart failure—and a …
imperative—to offset cell death in acute ischemic injury and chronic heart failure—and a …